Figures & data
Table 1. More frequently associated diseases in our vitiligo patients (n = 196)
Table 2. clinical subtypes of vitiligo in the sample
Table 3. Clinical and analytical differences between segmental/non segmental subtypes
Figure 1. Frequency of serologic altered values in patients (n = 196) and controls (n = 160). Comparison of serologic alterations between patient and control groups (p values are shown in the table at the top of the bars; asterisks are shown when values are < 0.05).
Figure 2. Frequency of altered parameters in case (n = 196) and control group (n = 160) compared by sex. Statistically significant p values (< 0,05) are shown with asterisk at the top of the bars: ATM and APGC levels between women belonging to vitiligo or control group showed significant differences (*p = 0,014, **p = 0.002 respectively).
